Premium
Microfluidics‐Based Pathogen Detection: A Highly Sensitive Molecular Detection Platform for Robust and Facile Diagnosis of Middle East Respiratory Syndrome (MERS) Corona Virus (Adv. Healthcare Mater. 17/2016)
Author(s) -
Jung Il Young,
You Jae Bem,
Choi Bo Ram,
Kim Ji Su,
Lee Hyun Kyung,
Jang Bora,
Jeong Han Saem,
Lee Kyuri,
Im Sung Gap,
Lee Hyukjin
Publication year - 2016
Publication title -
advanced healthcare materials
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.288
H-Index - 90
eISSN - 2192-2659
pISSN - 2192-2640
DOI - 10.1002/adhm.201670091
Subject(s) - middle east respiratory syndrome , microfluidics , middle east respiratory syndrome coronavirus , pathogen , nanotechnology , virus , virology , covid-19 , materials science , medicine , biology , microbiology and biotechnology , infectious disease (medical specialty) , disease , pathology
H. Lee and co‐workers demonstrate a definitive molecular diagnosis platform (DhITACT‐TR) for rapid and accurate detection of MERS coronavirus on page 2168. DhITACT‐TR offers a robust diagnosis of target RNA pathogens in pseudo‐serum specimens with minimum liquid handling as compared to conventional PCR analysis. In addition, a definitive diagnostic result can be achieved within 30 min by an optical detection.